$155 Million

Aerpio Pharmaceuticals, Inc.

PIPE

Placement Agent, May 2021

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO) is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which Aerpio believes that activation of Tie2 may have therapeutic potential.